Merck Millipore, the Life Science division of Merck, today (June 17) launched Simplicon™ RNA Reprogramming Technology, which uses synthetic self-replicating RNA to create large numbers of human induced pluripotent stem cells (iPSCs) using a single transfection step. This efficient reprogramming of somatic cells is accomplished without viral intermediates or host genome integration, offering a more defined and safer system for iPSC generation.

New regulations, increased use, flagging performance and signigicant maintenance main drivers to buy

Problem: Solvents are used in virtually every laboratory to perform routine research procedures as well as product quality control and medical and diagnostic tests. Laboratory staff are responsible for the documentation, staging, storage and transport of solvents, which compromises valuable time spent on research.

AFS® 8D and AFS® 16D Offer cost-effective solutions for analyzers’ degassed water needs up to 320 L daily Complementary water purification techniques ensure delivery of degassed clinical laboratory reagent water to comply

Today, newer purification technologies have proven able to compete with long-established distillation. Following a brief review of these purification technologies are data for performances of a single and double distillation system, and the Millipore Elix UV system.